Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sanlugen prepares novel cytarabine prodrugs

July 28, 2011

TM-400 receives FDA orphan drug status

July 27, 2011

TH-302 and bevacizumab enter clinical trial in astrocytoma

July 27, 2011

Hutchison MediPharma patents new HGF receptor inhibitors

July 27, 2011

EMA recommends orphan drug status for 4SC's resminostat

July 26, 2011

Orally active histone deacetylase inhibitor displays potent antitumor activity in vivo

July 26, 2011

New cyclin-dependent kinase 9 inhibitors presented by Vichem Chemie Kutato

July 26, 2011

Novartis claims novel agents for treatment of cancer

July 26, 2011

CHMP issues opinion on Zytiga in prostate cancer

July 25, 2011

Afinitor recommended for new European approval

July 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...